The role of innate immunity in spontaneous regression of cancer

Indian Journal of Cancer

Volumn 48, Issue 2, 2011, Pages 246-251

  Thomas, J A ^a   Badini, M ^b  

^a Rajarajeshwari Dental College   (India)

^b Dr Syamala Reddy Dental College   (India)

Author keywords

Acute infections; fever; innate immunity; leukocytes; tumor regression

Indexed keywords

CANCER VACCINE;

ACUTE DISEASE; BACTERIAL INFECTION; CANCER IMMUNIZATION; CANCER PREVENTION; CANCER REGRESSION; CANCER RISK; CHRONIC DISEASE; DENDRITIC CELL; HUMAN; INNATE IMMUNITY; MACROPHAGE; MYCOSIS; NATURAL KILLER CELL; NEOPLASM; NONHUMAN; PROTOZOAL INFECTION; REVIEW; TUMOR IMMUNITY; VIRUS INFECTION; ANIMAL; IMMUNOLOGY; PATHOLOGY;

ANIMALS; HUMANS; IMMUNITY, INNATE; NEOPLASMS;

EID: 84865599710     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.82887     Document Type: Review

References (43)

1. Everson TC. Spontaneous regression of cancer. Prog Clin Cancer 1967;3:79-95.
2. Cole WH, Everson TC. In Spontaneous regression of cancer. 1st ed. Philadelphia, PA: W. B. Saunders; 1966.
3. Le Dran HF. Traite des operations de chirurgie. Paris: C Osmont; 1942.
4. Hoption Cann SA, van Netten JP, van Netten C, Glover DW. Spontaneous regression: A hidden treasure buried in time. Med Hypotheses 2002;58:115-9.
5. http://www.cancer.gov. National cancer institute, United States. Dictionary of cancer terms. [Last updated on 2010 Sept, last cited on 2010 Oct 2010].
6. Rohdenburg GL. Fluctuations in the growth energy of malignant tumors in man, with especial reference to spontaneous recession. J Cancer Res 1918;3:193-225.
7. Fauvet J, Campagne J, Chavy A, Piet G. Cures, regressions and spontaneous remissions of cancer. La Revue du Praticien 1960;10:2349-84.
8. Nauts HC, Pelner L, Fowler GA. Sarcoma of the soft tissues other than lymphosarcoma, treated by toxin therapy. New York: Cancer Research Institute; 1969.
9. Graham NM, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis 1990;162:1277-82.
10. Brandts CH, Graninger W, Kremsner PG. Effect of paracetamol on parasitic clearance time in Plasmodium falciparum malaria. Lancet 1997;350:704-9.
11. Sugimura T, Fujimoto T, Motoyama H, Maruoka T, Korematu S, Asakuno Y, et al. Risks of antipyretics in young children with fever due to infectious disease. Acta paediatr Jpn 1994;36:375-8.
12. Doran TF, De Angelis C, Baumgardner RA, Mellits ED. Acetominophen: More harm than good for chickenpox? J Pediatr 1989;114:1045-8.
13. Kleef R, Jonas WB, Knogler W, Stenzinger W. Review of fever, cancer incidence and spontaneous remissions. Neuroimmunomodulation 2001;9:55-64.
14. zur Hausen H. Viruses and human cancers. Science 1991;254: 1167-73.
15. Parkin DM. The global burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-44.
16. Power D. The local distribution of cancer and cancer houses. Practitioner 1899;62:418-29.
17. Abel U, Becker N, Angerer R, Frentzel-Beyme R, Kaufmann M, Schlag P, et al. Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 1991;117:339
18. Busch W. Aus der sitzung der medicinischen section. Berliner Klinische Wochenschrift 1867;13:5-137.
19. Hoption Cann SA, van Netten JP, van Netten C. Dr William Coley and tumour regression: A place in history or in the future. Postgrad Med J 2003;79:672-80.
20. Seliger B, Ritz U, Ferrone S. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int J Cancer 2006;118:129-38.
21. Frumento G, Piazza T, Di Carlo E, Ferrini S. Targeting tumor-related immunosuppression for cancer immunotherapy. Endocr Metab Immune Disord Drug Targets 2006;6:233-7.
22. Hobohm U. Healing heat: Harnessing infection to fight cancer. Am Sci 2009;97:34.
23. MacAdam DH, Coley, editors. Spontaneous regression: cancer and the immune system, 1st ed. Philadelphia: Xilibris; 2003. p. 5-10.
24. W.H.O oral cancer estimates. Sweden: Malmo University; 2000. Available from: Http://www.who.int/mediacentre/news/releases/2003/pr27/en/. [cited in 2003].
25. Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, Mlecnik B, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005;353:2654-66.
26. Beck G, Habicht GS. Immunity and the invertebrates. Sci Am 1996;275:60-66.
27. Rus H, Cudrici C, Niculescu F. The role of the complement system in innate immunity. Immunol Res 2005;33:103-12.
28. Hobohm U, Stanford JL, Grange JM. PAMP in cancer immunotherapy. Crit Rev Immunol 2008;28:95-107.
29. Zhang G, Ghosh S. Toll-like receptor-mediated NF-κB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Investig 2001;107:13-9. 30. Medzhitov R, Janeway CA Jr. innate immune recognition and control of adaptive immune responses. Semin immunol 1998;10:351-3.
30. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat immunol 2008;9:503-10.
31. Hayakawa Y, Smyth MJ. Innate immune recognition and suppression of tumors. Adv Cancer Res 2006;95:293-322.
32. The future of things.com. Innate immunity to cancer. Available from: Http://thefutureofthings.com/news/1031/innate-immunity-tocancer. html. [cited in 2007].
33. Nasrallah AG, Miale TD. Decreased natural killer cell activity in children with untreated acute leukemia. Cancer Res 1983;43: 5580-5.
34. Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother 2001;50:391-6.
35. Wiemann B, Starnes CO. Coley's toxins, tumor necrosis factor and cancer research: A historical perspective. Pharmacol ther 1994; 64:529-64. 37. Kleef R, Jonas WB, Knogler W, Stenzinger W. Review of ever, cancer incidence and spontaneous remissions. Neuroimmunomodulation 2001;9:55-64.
36. Barbera-Guillem E, Nyhus JK, Wolford CC, Friece CR, Sampsel JW. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 2002;62:7042-9.
37. Kataki A, Scheid P, Piet M, Marie B, Martinet N, Martinet Y, et al. Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progression. J Lab Clin Med 2002;140:320-8.
38. al-Sarireh B, Eremin O. Tumour-associated macrophages (TAMS): Disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb 2000;45:1-16.
39. Whalen GF. Solid tumours and wounds: Transformed cells misunderstood as injured tissue? Lancet 1990; 336:1489-92.
40. Lerner DM, Stoudemire A, Rosenstein DL. Neuropsychiatric toxicity associated with cytokine therapies. Psychosomatics 1999;40: 428-35.
41. Carson WE, Yu H, Dierksheide J, Pfeffer K, Bouchard P, Clark R, et al. A fatal cytokine-induced systemic inflammatory response reveals a critical role for NK cells. J Immunol 1999;162:4943-51.
42. Jha A. Common cold virus may be new weapon to fight cancer. The guardian. Available from: Http://www.guardian.co.uk/ science/2007/jan/11/cancer. infectiousdiseases. [cited in 2007].
43. Abel U, Becker N, Angerer R, Frentzel-Beyme R, Kaufmann M, Schlag P, et al. Common infections in the history of cancer patients and controls. J Cancer Res Clin Oncol 1991;117:339-44.